NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

50 個領先的製藥 CMO 市場(2021 年):詳細分析-能力、結果、競爭和銷售潛力-主要製藥公司係列

Pharma Leader Series - Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021: In-depth Analysis of Top 50 Pharma CMOs - Capabilities, Results, Competition and Sales Potentials

出版商 Visiongain Ltd 商品編碼 1004465
出版日期 內容資訊 英文 395 Pages
商品交期: 最快1-2個工作天內
價格
50 個領先的製藥 CMO 市場(2021 年):詳細分析-能力、結果、競爭和銷售潛力-主要製藥公司係列 Pharma Leader Series - Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021: In-depth Analysis of Top 50 Pharma CMOs - Capabilities, Results, Competition and Sales Potentials
出版日期: 2021年01月06日內容資訊: 英文 395 Pages
簡介

激烈的競爭、嚴格的監管、研發放緩、利潤率收窄、強大的價格壓力和專利懸崖正在壓倒當今的製藥行業。眾所周知,製藥/生物製藥行業的未來取決於創新,而創新來自於合作和聯盟。

製造業外包和外包,無論是換取服務還是以戰略合作的形式,是一種新範式,通過將固定成本轉化為可變成本,為提高企業盈利能力提供了新的機會。執行定制合成以生產中間體、API 和劑型的合同製造商被認為對於藥物開發商更有效地開展業務變得越來越重要。...

新興經濟體的快速經濟增長也推動了藥品/生物製藥合同製造市場的發展。成本,曾經被認為是外包的唯一原因,現在通過質量和可靠性來實現。

本報告調查了醫藥 CMO 市場的 50 家主要公司,以及主要公司的主要業務戰略、產品映射、提供的服務、公司的近期活動、主要增長因素和市場。我們提供的信息包括作為影響我們業務的問題。

目錄

第 1 章報告概述

第 2 章執行摘要

  • 醫藥製造板塊有望保持全球市場優勢
  • COVID-19 對醫藥產品合同製造市場的影響

第三章市場動態

  • 影響增長的因素
    • 產品和流程創新
    • 持續關註生產力
    • 降低成本
    • 危機管理
    • 嚴格的規定
    • 專利到期日
    • 研發成功率下降
  • 市場增長因素
    • 對生物仿製藥的需求增加
    • 越來越關注隔離藥物和特殊藥物
    • 通用:生長或抑制因素
    • 對藥物開發服務的需求不斷增加
    • 與生物/製藥製造商的給藥技術公司開展戰略合作
  • 世界市場的機會
    • 缺乏製造和包裝能力
    • 製藥公司正在尋找降低藥品成本的方法
    • 新型給藥技術的必要性
    • 化學原料藥有望在重點轉向生物原料藥後復甦
  • 生長抑制
    • 仿製藥製造商的反向整合
    • 美國仿製藥使用費法和 API 製造
    • 代工製造的挑戰
    • 市場評估挑戰:供需
  • SWOT 分析
  • 波特五力分析

第 4 章全球醫藥合同製造市場

  • 產業結構概覽
    • 主要製藥公司概況
    • 中小代工企業概況
    • 製藥情況
    • 外包的目的
    • 合同製造型
    • 合適的服務提供商
    • 外包的好處
    • 外包的缺點
    • 外包
    • 代工組織的核心職能
    • 合同製造組織提供的服務

第 5 章全球醫藥合同製造市場

  • 概述
    • COVID-19 之前的市場狀況分析
    • 市場V型複蘇格局分析
    • 市場W型複蘇格局分析
    • 市場U型複蘇格局分析
    • 市場L型複蘇形態分析
  • 區域市場概覽
    • COVID-19 之前的市場狀況分析
    • 市場V型複蘇格局分析
    • 市場W型複蘇格局分析
    • 市場U型複蘇格局分析
    • 市場L型複蘇形態分析

第6章競爭形勢

  • 戰略與戰術:明智外包的重要性
  • 市場領導者
  • 市場份額
    • 原料藥和原料藥
    • 固體劑型
    • 液體劑型
    • 半固體劑型
  • 合同調查
    • 市場領導者
    • 市場份額

第七章 20 大 CMO 主宰世界市場

  • 全球市場主要 CMO 現狀
  • Cardinal Health, Inc. 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • F. Hoffmann-La Roche Ltd
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 公司近期動向
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 輝瑞公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 公司近期動向
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 拜耳公司
    • 企業信息
    • 公司簡介
    • 企業融資 (2019)
    • 公司提供的產品
    • 某公司生產基地
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 葛蘭素史克製藥公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Cepia Sanofi Company(賽諾菲的母公司)
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Fujifilm Diosynth Biotechnologies(默克公司的子公司)
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 艾伯維公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Thermo Fisher Scientific Inc.
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • C.H. Boehringer Sohn AG & Ko. KG Company
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • SAFC Biosciences Company (Merck KGaA 子公司)
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 梯瓦製藥公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 贏創德固賽公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 百特生物製藥解決方案公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Koninklijke DSM N.V.(皇家帝斯曼)公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 龍沙股份公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 公司近期動向
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Nipro Corporation
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Aurobindo Pharma Ltd.
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Charles River Laboratories International, Inc. 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 雷迪博士實驗室公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望

第八章 20 家主要中端 CMO 公司在全球醫藥市場確立穩固地位

  • 中端CMO在世界市場的成就
  • Fareva 製藥公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 公司近期動向
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 藥明康德公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 浙江海正藥業公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 華邦生命科學有限公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Alkermes 生物技術公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 齊格弗裡德控股公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Recipharm AB 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 百康有限公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Almac 集團公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 維特製藥公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 迪維實驗室有限公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Cambrex Corporation 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 三星生物公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • DPT 實驗室有限公司(Mylan NV) 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Aenova 集團公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 大東製藥株式會社
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Ajinomoto Bio-Pharma Services Company
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 大步醫藥科技有限公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Consort Medical plc
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Alcami Corporation Company
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望

第9章全球醫藥市場值得關注的10家主要CMO公司

  • 推動小規模 CMO 增長的長長的生物製藥管道
  • Catalent Pharma Solutions Inc.
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Avid Bioservices Inc.
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 某公司生產基地
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Famar SA 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 寶來製藥公司
    • 公司快照
    • 公司簡介
    • 企業產品標桿
    • 公司財務狀況
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球眼科市場公司的主要競爭對手
    • 公司未來展望
  • Therapy Biopharma, Inc.公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • 芬歐匯川製藥公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Delpharm SAS 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 公司近期動向
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Corden Pharma 國際公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Biomay AG 公司
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手
    • 公司未來展望
  • Biophore India Pharmaceuticals Private Limited Company
    • 企業信息
    • 公司簡介
    • 公司提供的產品
    • 企業融資 (2019)
    • 近期公司動態
    • 企業 SWOT 分析
    • 全球 CMO 市場的主要競爭對手

第 10 章結論和建議

  • 到 2031 年,產品重組會推動增長嗎?
  • 生物製藥製造需求促進增長(2021-2031)
  • 發達國家客戶的需求最高
  • 到 2031 年生物技術資金對合同製造的影響

第 11 章其他 50 家合同製造公司名單

第 12 章詞彙表

目錄
Product Code: PHA1026

Are you in the global race? Where do you stand in the cut throat global competition?

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today's drug industry. <>It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

Buy this report to find out an analysis of strategies adopted by Top 50 players in the market to stay ahead of their competitor.

Contract manufacturing and outsourcing in the form of pay for services or strategic collaboration has resulted in the development of a new paradigm that offers new opportunities to companies for improving their bottom lines through the conversion of fixed costs to variable costs. Contract manufacturers that perform custom synthesis and produce intermediates, active pharmaceutical ingredients and dosage forms are becoming increasingly important for the drug developers to conduct their business more efficiently. <>Rapid economic growth in the emerging markets is also advancing the pharmaceutical/biopharmaceutical contract manufacturing market. Cost, once considered the only reason for outsourcing, is now accomplished by quality and reliability.

How this report will benefit you?

The 395-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the global top 50 rankings, top business strategies adopted by the key players, product mapping, services provided, recent activities of the companies, key drivers and challenges affecting the market.

Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 434-page report you will receive 400+ tables and 300+ figures- all unavailable elsewhere.

Market Insights

Boots Contract Manufacturing, a unit of Wallgreen Boots Alliance Inc., was the leader in the non-sterile liquid contract manufacturing market with a xx% share. Catalent Pharma Solutions had a 6.8% share, and GlaxoSmithKline (GSK) and Perrigo Company PLC also had notable shares in this market. Mylan N.V., Lyne Laboratories and Wockhardt Ltd. are other contributors in the non-sterile liquid dosage form market via contract manufacturing. <>Many renowned pharmaceutical companies such as Boehringer Ingelheim, AbbVie Inc., Dr. Reddy's, Pharmaceutical International GmbH and Jubilant Lifesciences also contributed to this market, holding a 69.3% cumulative market share.

COVID-19 Impact on Pharmaceutical Contract Manufacturing Market

Due to the recent outbreak of COVID-19, the changing delivery chain scenario is likely to have a prominent effect in the short term on global contract manufacturing, including China. The demand for large-scale contract manufacturing is expected to increase significantly as pharmaceutical companies start full-scale operations following the coronavirus outbreak. After the end of the COVID-19 pandemic, several organizations will seek to increase their productivity to meet the growing demand. This means that such larger companies should appoint contract development and manufacturing organizations to deal with losses suffered during the crisis. In addition, numerous governmental bodies develop innovative plans to boost contract development and producing organizations to boost productivity for other bigger organizations.

By ordering and reading our brand-new report today you stay better informed and ready to act. Visiongain's study is intended for anyone requiring commercial analyses for the top 50 pharmaceutical contract manufacturing market. You find data, trends and predictions.

Companies Profiled in the Report:

  • AbbVie Inc Company
  • Aenova Group Company
  • Ajinomoto Bio-Pharma Services Company
  • Alcami Corporation Company
  • Alkermes Biotechnology company
  • Almac Group Company
  • Aurobindo Pharma Ltd.
  • Avid Bioservices Inc.
  • Baxter Biopharma Solutions Company
  • Bayer AG Company
  • Biocon Limited Company
  • Biomay AG Company
  • Biophore India Pharmaceuticals Private Limited Company
  • Bora Pharmaceuticals Company
  • C.H. Boehringer Sohn AG & Ko. KG Company
  • Cambrex Corporation Company
  • Cardinal Health, Inc. Company
  • Catalent Pharma Solutions Inc.
  • Cepia Sanofi Company (Parental of Sanofi)
  • Charles River Laboratories International, Inc. Company
  • Consort Medical plc
  • Corden Pharma International Company
  • Daito Pharmaceutical Co., Ltd. Company
  • Delpharm SAS Company
  • Divi's Laboratories Ltd
  • DPT Laboratories, Ltd. (Mylan N.V.) Company
  • Dr. Reddy's Laboratories Company
  • Evonik Degussa Company
  • F. Hoffmann-La Roche Ltd
  • Famar S.A. Company
  • Fareva Pharmaceuticals Company
  • Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
  • GlaxoSmithKline Pharmaceutical Company
  • Huapont Life Sciences Co Ltd Company
  • Koninklijke DSM N.V. (Royal DSM) Company
  • Lonza AG Company
  • Nipro Corporation
  • Pfizer Company
  • Recipharm AB Company
  • SAFC Biosciences (Merck KGaA Subsidiaries) Company
  • Samsung Biologics Company
  • Siegfried Holding Company
  • Strides Pharma Science Limited Company
  • Teva Pharmaceuticals Company
  • Therapure Biopharma, Inc. Company
  • Thermo Fisher Scientific Inc.
  • UPM Pharmaceuticals Company
  • Vetter Pharma Company
  • WuXi AppTec Company
  • Zhejiang Hisun Pharmaceutical Company

Buy our report today “Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021 : In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials ”. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Report Overview

  • 1.1 Scope of Report
  • 1.2 Why You Should Buy This Report
  • 1.3 How This Report Delivers
  • 1.4 Key Questions Answered by This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
  • 1.7 Market Evaluation & Forecasting Methodology
  • 1.8 COIVD-19 Impact Recovery Pattern Analysis
    • 1.8.1 V-Shaped Recovery
    • 1.8.2 U-Shaped Recovery
    • 1.8.3 W-Shaped Recovery
    • 1.8.4 L-Shaped Recovery
  • 1.9 Frequently Asked Questions (FAQ)
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2 Executive Summary

  • 2.1 Pharmaceutical Product Manufacturing Segment is Expected to Maintain its Dominance in the Global Market
  • 2.2 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market

3 Market Dynamics

  • 3.1 Factors Affecting Growth
    • 3.1.1 Product and Process Innovation
    • 3.1.2 Continuing Focus on Productivity
    • 3.1.3 Cost Savings
    • 3.1.4 Risk Management
    • 3.1.5 Stringent Regulations
    • 3.1.6 Patent Expirations
    • 3.1.7 Decreasing Research and Development Success Rates
  • 3.2 Market Drivers
    • 3.2.1 Increasing Demand of Biosimilars
    • 3.2.2 Increased Focus on Orphan and Specialty Drugs
    • 3.2.3 Generics: A Driver or Restraint?
    • 3.2.4 Increasing Demand for Formulation Development Services
    • 3.2.5 Bio/Pharmaceutical Manufacturers' Move Toward Strategic Collaboration With Drug Delivery Technology Companies
  • 3.3 Opportunities in the Global Market
    • 3.3.1 Lack of Manufacturing and Packaging Capabilities
    • 3.3.2 Pharma Companies Will Continue To Look For Ways To Cut Drug Costs
    • 3.3.3 Need for New Drug Delivery Technologies
    • 3.3.4 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs
  • 3.4 Growth Restrain
    • 3.4.1 Backwards Integration for Generics Manufacturers
    • 3.4.2 The US Generic Drug User Fee Act and API Manufacturing
    • 3.4.3 Challenges in Contract Manufacturing
    • 3.4.4 Challenges in Assessing the Market: Supply versus Demand
  • 3.5 SWOT Analysis
  • 3.6 Porter's Five Forces Analysis
    • 3.6.1 What are Porter Five (5) Forces
    • 3.6.2 Threat of New Entrants (Low to Moderate)
    • 3.6.3 Rivalry Among the Existing Players (High)
    • 3.6.4 Bargaining Power of Suppliers (Low)
    • 3.6.5 Threats from Substitute Products (Low to Moderate)
    • 3.6.6 Bargaining Power of Buyers (High)

4 Global Pharmaceutical Contract Manufacturing Market

  • 4.1 Industry Structure Overview
    • 4.1.1 Big Pharmaceutical Contract Manufacturing Companies Overview
    • 4.1.2 Small & Mid-size Pharmaceutical Contract Manufacturing Companies Overview
    • 4.1.3 Pharmaceutical Landscape
    • 4.1.4 Objectives of Outsourcing
    • 4.1.5 Contract Manufacturing Types
    • 4.1.6 Suitable Services Provider
    • 4.1.7 Benefits of Outsourcing
    • 4.1.8 Drawbacks of Outsourcing
    • 4.1.9 Outsourcing
    • 4.1.10 Core Capabilities of Contract Manufacturing Organization
    • 4.1.11 Services Offered by Contract Manufacturing Organizations

5 Global Pharmaceutical Contract Manufacturing Market

  • 5.1 Overview
    • 5.1.1 Analysis of Market Status Before COVID-19
    • 5.1.2 Analysis of Market V-Shaped Recovery Pattern
    • 5.1.3 Analysis of Market W-Shaped Recovery Pattern
    • 5.1.4 Analysis of Market U-Shaped Recovery Pattern
    • 5.1.5 Analysis of Market L-Shaped Recovery Pattern
  • 5.2 Regional Market Overview
    • 5.2.1 Analysis of Market Status Before COVID-19
    • 5.2.2 Analysis of Market V-Shaped Recovery Pattern
    • 5.2.3 Analysis of Market W-Shaped Recovery Pattern
    • 5.2.4 Analysis of Market U-Shaped Recovery Pattern
    • 5.2.5 Analysis of Market L-Shaped Recovery Pattern

6 Competitive Landscape

  • 6.1 Strategy and Tactics: The Importance of Outsourcing Wisely
  • 6.2 Market Leaders
  • 6.3 Market Shares
    • 6.3.1 Bulk Drugs and APIs
    • 6.3.2 Solid Dosage Forms
    • 6.3.3 Liquid Dosage Forms
    • 6.3.4 Semi-Solid Dosage Forms
  • 6.4 Contract Research
    • 6.4.1 Market Leaders
    • 6.4.2 Market Shares

7 Top 20 Big CMOs Dominating the Global Market

  • 7.1 What is the Current Status of Big CMOs in the Global Market?
  • 7.2 Cardinal Health, Inc. Company
    • 7.2.1 Company Information
    • 7.2.2 Company Overview
    • 7.2.3 Company Product Offerings
    • 7.2.4 Company Financials, 2019
    • 7.2.5 Company Recent Developments
    • 7.2.6 Company SWOT Analysis
    • 7.2.7 Company Key Competitors in the Global CMO Market
    • 7.2.8 Company Future Outlook
  • 7.3 F. Hoffmann-La Roche Ltd
    • 7.3.1 Company Information
    • 7.3.2 Company Overview
    • 7.3.3 Company Product Offerings
    • 7.3.4 Company Manufacturing Locations
    • 7.3.5 Company Financials, 2019
    • 7.3.6 Company Recent Developments
    • 7.3.7 Company SWOT Analysis
    • 7.3.8 Company Key Competitors in the Global CMO Market
    • 7.3.9 Company Future Outlook
  • 7.4 Pfizer Company
    • 7.4.1 Company Information
    • 7.4.2 Company Overview
    • 7.4.3 Company Product Offerings
    • 7.4.4 Company Financials, 2019
    • 7.4.5 Company Recent Developments
    • 7.4.6 Company SWOT Analysis
    • 7.4.7 Company Key Competitors in the Global CMO Market
    • 7.4.8 Company Future Outlook
  • 7.5 Bayer AG Company
    • 7.5.1 Company Information
    • 7.5.2 Company Overview
    • 7.5.3 Company Financials, 2019
    • 7.5.4 Company Product Offerings
    • 7.5.5 Company Manufacturing Locations
    • 7.5.6 Company Recent Developments
    • 7.5.7 Company SWOT Analysis
    • 7.5.8 Company Key Competitors in the Global CMO Market
    • 7.5.9 Company Future Outlook
  • 7.6 GlaxoSmithKline Pharmaceutical Company
    • 7.6.1 Company Information
    • 7.6.2 Company Overview
    • 7.6.3 Company Product Offerings
    • 7.6.4 Company Manufacturing Locations
    • 7.6.5 Company Financials, 2019
    • 7.6.6 Company Recent Developments
    • 7.6.7 Company SWOT Analysis
    • 7.6.8 Company Key Competitors in the Global CMO Market
    • 7.6.9 Company Future Outlook
  • 7.7 Cepia Sanofi Company (Parental of Sanofi)
    • 7.7.1 Company Information
    • 7.7.2 Company Overview
    • 7.7.3 Company Product Offerings
    • 7.7.4 Company Financials, 2019
    • 7.7.5 Company Recent Developments
    • 7.7.6 Company SWOT Analysis
    • 7.7.7 Company Key Competitors in the Global CMO Market
    • 7.7.8 Company Future Outlook
  • 7.8 Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
    • 7.8.1 Company Information
    • 7.8.2 Company Overview
    • 7.8.3 Company Product Offerings
    • 7.8.4 Company Financials, 2019
    • 7.8.5 Company Recent Developments
    • 7.8.6 Company SWOT Analysis
    • 7.8.7 Company Key Competitors in the Global CMO Market
    • 7.8.8 Company Future Outlook
  • 7.9 AbbVie Inc Company
    • 7.9.1 Company Information
    • 7.9.2 Company Overview
    • 7.9.3 Company Product Offerings
    • 7.9.4 Company Manufacturing Locations
    • 7.9.5 Company Financials, 2019
    • 7.9.6 Company Recent Developments
    • 7.9.7 Company SWOT Analysis
    • 7.9.8 Company Key Competitors in the Global CMO Market
    • 7.9.9 Company Future Outlook
  • 7.10 Thermo Fisher Scientific Inc.
    • 7.10.1 Company Information
    • 7.10.2 Company Overview
    • 7.10.3 Company Product Offerings
    • 7.10.4 Company Financials, 2019
    • 7.10.5 Company Recent Developments
    • 7.10.6 Company SWOT Analysis
    • 7.10.7 Company Key Competitors in the Global CMO Market
    • 7.10.8 Company Future Outlook
  • 7.11 C.H. Boehringer Sohn AG & Ko. KG Company
    • 7.11.1 Company Information
    • 7.11.2 Company Overview
    • 7.11.3 Company Product Offerings
    • 7.11.4 Company Financials, 2019
    • 7.11.5 Company Recent Developments
    • 7.11.6 Company SWOT Analysis
    • 7.11.7 Company Key Competitors in the Global CMO Market
    • 7.11.8 Company Future Outlook
  • 7.12 SAFC Biosciences (Merck KGaA Subsidiaries) Company
    • 7.12.1 Company Information
    • 7.12.2 Company Overview
    • 7.12.3 Company Product Offerings
    • 7.12.4 Company Financials, 2019
    • 7.12.5 Company Recent Developments
    • 7.12.6 Company SWOT Analysis
    • 7.12.7 Company Key Competitors in the Global CMO Market
    • 7.12.8 Company Future Outlook
  • 7.13 Teva Pharmaceuticals Company
    • 7.13.1 Company Information
    • 7.13.2 Company Overview
    • 7.13.3 Company Product Offerings
    • 7.13.4 Company Financials, 2019
    • 7.13.5 Company Recent Developments
    • 7.13.6 Company SWOT Analysis
    • 7.13.7 Company Key Competitors in the Global CMO Market
    • 7.13.8 Company Future Outlook
  • 7.14 Evonik Degussa Company
    • 7.14.1 Company Information
    • 7.14.2 Company Overview
    • 7.14.3 Company Product Offerings
    • 7.14.4 Company Financials, 2019
    • 7.14.5 Company Recent Developments
    • 7.14.6 Company SWOT Analysis
    • 7.14.7 Company Key Competitors in the Global CMO Market
    • 7.14.8 Company Future Outlook
  • 7.15 Baxter Biopharma Solutions Company
    • 7.15.1 Company Information
    • 7.15.2 Company Overview
    • 7.15.3 Company Product Offerings
    • 7.15.4 Company Manufacturing Locations
    • 7.15.5 Company Financials, 2019
    • 7.15.6 Company Recent Developments
    • 7.15.7 Company SWOT Analysis
    • 7.15.8 Company Key Competitors in the Global CMO Market
    • 7.15.9 Company Future Outlook
  • 7.16 Koninklijke DSM N.V. (Royal DSM) Company
    • 7.16.1 Company Information
    • 7.16.2 Company Overview
    • 7.16.3 Company Product Offerings
    • 7.16.4 Company Manufacturing Locations
    • 7.16.5 Company Financials, 2019
    • 7.16.6 Company Recent Developments
    • 7.16.7 Company SWOT Analysis
    • 7.16.8 Company Key Competitors in the Global CMO Market
    • 7.16.9 Company Future Outlook
  • 7.17 Lonza AG Company
    • 7.17.1 Company Information
    • 7.17.2 Company Overview
    • 7.17.3 Company Product Offerings
    • 7.17.4 Company Manufacturing Locations
    • 7.17.5 Company Financials, 2019
    • 7.17.6 Company Recent Developments
    • 7.17.7 Company SWOT Analysis
    • 7.17.8 Company Key Competitors in the Global CMO Market
    • 7.17.9 Company Future Outlook
  • 7.18 Nipro Corporation
    • 7.18.1 Company Information
    • 7.18.2 Company Overview
    • 7.18.3 Company Product Offerings
    • 7.18.4 Company Financials, 2019
    • 7.18.5 Company Recent Developments
    • 7.18.6 Company SWOT Analysis
    • 7.18.7 Company Key Competitors in the Global CMO Market
    • 7.18.8 Company Future Outlook
  • 7.19 Aurobindo Pharma Ltd.
    • 7.19.1 Company Information
    • 7.19.2 Company Overview
    • 7.19.3 Company Product Offerings
    • 7.19.4 Company Manufacturing Locations
    • 7.19.5 Company Financials, 2019
    • 7.19.6 Company Recent Developments
    • 7.19.7 Company SWOT Analysis
    • 7.19.8 Company Key Competitors in the Global CMO Market
    • 7.19.9 Company Future Outlook
  • 7.20 Charles River Laboratories International, Inc. Company
    • 7.20.1 Company Information
    • 7.20.2 Company Overview
    • 7.20.3 Company Product Offerings
    • 7.20.4 Company Financials, 2019
    • 7.20.5 Company Recent Developments
    • 7.20.6 Company SWOT Analysis
    • 7.20.7 Company Key Competitors in the Global CMO Market
    • 7.20.8 Company Future Outlook
  • 7.21 Dr. Reddy's Laboratories Company
    • 7.21.1 Company Information
    • 7.21.2 Company Overview
    • 7.21.3 Company Product Offerings
    • 7.21.4 Company Manufacturing Locations
    • 7.21.5 Company Financials, 2019
    • 7.21.6 Company Recent Developments
    • 7.21.7 Company SWOT Analysis
    • 7.21.8 Company Key Competitors in the Global CMO Market
    • 7.21.9 Company Future Outlook

8 Top 20 Mid-Range CMOs with Strong Foothold in the Global Pharma Market

  • 8.1 How are the Mid-Range CMOs Performing in the Global Market?
  • 8.2 Fareva Pharmaceuticals Company
    • 8.2.1 Company Information
    • 8.2.2 Company Overview
    • 8.2.3 Company Product Offerings
    • 8.2.4 Company Financials, 2019
    • 8.2.5 Company Recent Developments
    • 8.2.6 Company SWOT Analysis
    • 8.2.7 Company Key Competitors in the Global CMO Market
    • 8.2.8 Company Future Outlook
  • 8.3 WuXi AppTec Company
    • 8.3.1 Company Information
    • 8.3.2 Company Overview
    • 8.3.3 Company Product Offerings
    • 8.3.4 Company Manufacturing Locations
    • 8.3.5 Company Financials, 2019
    • 8.3.6 Company Recent Developments
    • 8.3.7 Company SWOT Analysis
    • 8.3.8 Company Key Competitors in the Global CMO Market
    • 8.3.9 Company Future Outlook
  • 8.4 Zhejiang Hisun Pharmaceutical Company
    • 8.4.1 Company Information
    • 8.4.2 Company Overview
    • 8.4.3 Company Product Offerings
    • 8.4.4 Company Manufacturing Locations
    • 8.4.5 Company Financials, 2019
    • 8.4.6 Company Recent Developments
    • 8.4.7 Company SWOT Analysis
    • 8.4.8 Company Key Competitors in the Global CMO Market
    • 8.4.9 Company Future Outlook
  • 8.5 Huapont Life Sciences Co Ltd Company
    • 8.5.1 Company Information
    • 8.5.2 Company Overview
    • 8.5.3 Company Product Offerings
    • 8.5.4 Company Financials, 2019
    • 8.5.5 Company Recent Developments
    • 8.5.6 Company SWOT Analysis
    • 8.5.7 Company Key Competitors in the Global CMO Market
    • 8.5.8 Company Future Outlook
  • 8.6 Alkermes Biotechnology company
    • 8.6.1 Company Information
    • 8.6.2 Company Overview
    • 8.6.3 Company Product Offerings
    • 8.6.4 Company Manufacturing Locations
    • 8.6.5 Company Financials, 2019
    • 8.6.6 Company Recent Developments
    • 8.6.7 Company SWOT Analysis
    • 8.6.8 Company Key Competitors in the Global CMO Market
    • 8.6.9 Company Future Outlook
  • 8.7 Siegfried Holding Company
    • 8.7.1 Company Information
    • 8.7.2 Company Overview
    • 8.7.3 Company Product Offerings
    • 8.7.4 Company Financials, 2019
    • 8.7.5 Company Recent Developments
    • 8.7.6 Company SWOT Analysis
    • 8.7.7 Company Key Competitors in the Global CMO Market
    • 8.7.8 Company Future Outlook
  • 8.8 Recipharm AB Company
    • 8.8.1 Company Information
    • 8.8.2 Company Overview
    • 8.8.3 Company Product Offerings
    • 8.8.4 Company Financials, 2019
    • 8.8.5 Company Recent Developments
    • 8.8.6 Company SWOT Analysis
    • 8.8.7 Company Key Competitors in the Global CMO Market
    • 8.8.8 Company Future Outlook
  • 8.9 Biocon Limited Company
    • 8.9.1 Company Information
    • 8.9.2 Company Overview
    • 8.9.3 Company Product Offerings
    • 8.9.4 Company Financials, 2019
    • 8.9.5 Company Recent Developments
    • 8.9.6 Company SWOT Analysis
    • 8.9.7 Company Key Competitors in the Global CMO Market
    • 8.9.8 Company Future Outlook
  • 8.10 Almac Group Company
    • 8.10.1 Company Information
    • 8.10.2 Company Overview
    • 8.10.3 Company Product Offerings
    • 8.10.4 Company Financials, 2019
    • 8.10.5 Company Recent Developments
    • 8.10.6 Company SWOT Analysis
    • 8.10.7 Company Key Competitors in the Global CMO Market
    • 8.10.8 Company Future Outlook
  • 8.11 Vetter Pharma Company
    • 8.11.1 Company Information
    • 8.11.2 Company Overview
    • 8.11.3 Company Product Offerings
    • 8.11.4 Company Financials, 2019
    • 8.11.5 Company Recent Developments
    • 8.11.6 Company SWOT Analysis
    • 8.11.7 Company Key Competitors in the Global CMO Market
    • 8.11.8 Company Future Outlook
  • 8.12 Divi's Laboratories Ltd
    • 8.12.1 Company Information
    • 8.12.2 Company Overview
    • 8.12.3 Company Product Offerings
    • 8.12.4 Company Financials, 2019
    • 8.12.5 Company Recent Developments
    • 8.12.6 Company SWOT Analysis
    • 8.12.7 Company Key Competitors in the Global CMO Market
    • 8.12.8 Company Future Outlook
  • 8.13 Cambrex Corporation Company
    • 8.13.1 Company Information
    • 8.13.2 Company Overview
    • 8.13.3 Company Product Offerings
    • 8.13.4 Company Financials, 2019
    • 8.13.5 Company Recent Developments
    • 8.13.6 Company SWOT Analysis
    • 8.13.7 Company Key Competitors in the Global CMO Market
    • 8.13.8 Company Future Outlook
  • 8.14 Samsung Biologics Company
    • 8.14.1 Company Information
    • 8.14.2 Company Overview
    • 8.14.3 Company Product Offerings
    • 8.14.4 Company Financials, 2019
    • 8.14.5 Company Recent Developments
    • 8.14.6 Company SWOT Analysis
    • 8.14.7 Company Key Competitors in the Global CMO Market
    • 8.14.8 Company Future Outlook
  • 8.15 DPT Laboratories, Ltd. (Mylan N.V.) Company
    • 8.15.1 Company Information
    • 8.15.2 Company Overview
    • 8.15.3 Company Product Offerings
    • 8.15.4 Company Financials, 2019
    • 8.15.5 Company Recent Developments
    • 8.15.6 Company SWOT Analysis
    • 8.15.7 Company Key Competitors in the Global CMO Market
    • 8.15.8 Company Future Outlook
  • 8.16 Aenova Group Company
    • 8.16.1 Company Information
    • 8.16.2 Company Overview
    • 8.16.3 Company Product Offerings
    • 8.16.4 Company Financials, 2019
    • 8.16.5 Company Recent Developments
    • 8.16.6 Company SWOT Analysis
    • 8.16.7 Company Key Competitors in the Global CMO Market
    • 8.16.8 Company Future Outlook
  • 8.17 Daito Pharmaceutical Co., Ltd. Company
    • 8.17.1 Company Information
    • 8.17.2 Company Overview
    • 8.17.3 Company Product Offerings
    • 8.17.4 Company Financials, 2019
    • 8.17.5 Company Recent Developments
    • 8.17.6 Company SWOT Analysis
    • 8.17.7 Company Key Competitors in the Global CMO Market
    • 8.17.8 Company Future Outlook
  • 8.18 Ajinomoto Bio-Pharma Services Company
    • 8.18.1 Company Information
    • 8.18.2 Company Overview
    • 8.18.3 Company Product Offerings
    • 8.18.4 Company Financials, 2019
    • 8.18.5 Company Recent Developments
    • 8.18.6 Company SWOT Analysis
    • 8.18.7 Company Key Competitors in the Global CMO Market
    • 8.18.8 Company Future Outlook
  • 8.19 Strides Pharma Science Limited Company
    • 8.19.1 Company Information
    • 8.19.2 Company Overview
    • 8.19.3 Company Product Offerings
    • 8.19.4 Company Financials, 2019
    • 8.19.5 Company Recent Developments
    • 8.19.6 Company SWOT Analysis
    • 8.19.7 Company Key Competitors in the Global CMO Market
    • 8.19.8 Company Future Outlook
  • 8.20 Consort Medical plc
    • 8.20.1 Company Information
    • 8.20.2 Company Overview
    • 8.20.3 Company Product Offerings
    • 8.20.4 Company Financials, 2019
    • 8.20.5 Company Recent Developments
    • 8.20.6 Company SWOT Analysis
    • 8.20.7 Company Key Competitors in the Global CMO Market
    • 8.20.8 Company Future Outlook
  • 8.21 Alcami Corporation Company
    • 8.21.1 Company Information
    • 8.21.2 Company Overview
    • 8.21.3 Company Product Offerings
    • 8.21.4 Company Financials, 2019
    • 8.21.5 Company Recent Developments
    • 8.21.6 Company SWOT Analysis
    • 8.21.7 Company Key Competitors in the Global CMO Market
    • 8.21.8 Company Future Outlook

9 Top 10 CMOs to Watch in the Global Pharma Market

  • 9.1 The Long Biopharmaceutical Pipeline Will Also Act As A Driver For Growth Of Small CMOs
  • 9.2 Catalent Pharma Solutions Inc.
    • 9.2.1 Company Information
    • 9.2.2 Company Overview
    • 9.2.3 Company Product Offerings
    • 9.2.4 Company Manufacturing Locations
    • 9.2.5 Company Financials, 2019
    • 9.2.6 Company Recent Developments
    • 9.2.7 Company SWOT Analysis
    • 9.2.8 Company Key Competitors in the Global CMO Market
    • 9.2.9 Company Future Outlook
  • 9.3 Avid Bioservices Inc.
    • 9.3.1 Company Information
    • 9.3.2 Company Overview
    • 9.3.3 Company Product Offerings
    • 9.3.4 Company Manufacturing Locations
    • 9.3.5 Company Financials, 2019
    • 9.3.6 Company Recent Developments
    • 9.3.7 Company SWOT Analysis
    • 9.3.8 Company Key Competitors in the Global CMO Market
    • 9.3.9 Company Future Outlook
  • 9.4 Famar S.A. Company
    • 9.4.1 Company Information
    • 9.4.2 Company Overview
    • 9.4.3 Company Product Offerings
    • 9.4.4 Company Financials, 2019
    • 9.4.5 Company Recent Developments
    • 9.4.6 Company SWOT Analysis
    • 9.4.7 Company Key Competitors in the Global CMO Market
    • 9.4.8 Company Future Outlook
  • 9.5 Bora Pharmaceuticals Company
    • 9.5.1 Company Snapshot
    • 9.5.2 Company Overview
    • 9.5.3 Company Product Benchmarking
    • 9.5.4 Company Financial Profile
    • 9.5.5 Company Recent Developments
    • 9.5.6 Company SWOT Analysis
    • 9.5.7 Company Key Competitors in the Global Ophthalmic Market
    • 9.5.8 Company Future Outlook
  • 9.6 Therapure Biopharma, Inc. Company
    • 9.6.1 Company Information
    • 9.6.2 Company Overview
    • 9.6.3 Company Product Offerings
    • 9.6.4 Company Financials, 2019
    • 9.6.5 Company Recent Developments
    • 9.6.6 Company SWOT Analysis
    • 9.6.7 Company Key Competitors in the Global CMO Market
    • 9.6.8 Company Future Outlook
  • 9.7 UPM Pharmaceuticals Company
    • 9.7.1 Company Information
    • 9.7.2 Company Overview
    • 9.7.3 Company Product Offerings
    • 9.7.4 Company Financials, 2019
    • 9.7.5 Company Recent Developments
    • 9.7.6 Company SWOT Analysis
    • 9.7.7 Company Key Competitors in the Global CMO Market
    • 9.7.8 Company Future Outlook
  • 9.8 Delpharm SAS Company
    • 9.8.1 Company Information
    • 9.8.2 Company Overview
    • 9.8.3 Company Product Offerings
    • 9.8.4 Company Financials, 2019
    • 9.8.5 Company Recent Developments
    • 9.8.6 Company SWOT Analysis
    • 9.8.7 Company Key Competitors in the Global CMO Market
    • 9.8.8 Company Future Outlook
  • 9.9 Corden Pharma International Company
    • 9.9.1 Company Information
    • 9.9.2 Company Overview
    • 9.9.3 Company Product Offerings
    • 9.9.4 Company Financials, 2019
    • 9.9.5 Company Recent Developments
    • 9.9.6 Company SWOT Analysis
    • 9.9.7 Company Key Competitors in the Global CMO Market
    • 9.9.8 Company Future Outlook
  • 9.10 Biomay AG Company
    • 9.10.1 Company Information
    • 9.10.2 Company Overview
    • 9.10.3 Company Product Offerings
    • 9.10.4 Company Financials, 2019
    • 9.10.5 Company Recent Developments
    • 9.10.6 Company SWOT Analysis
    • 9.10.7 Company Key Competitors in the Global CMO Market
    • 9.10.8 Company Future Outlook
  • 9.11 Biophore India Pharmaceuticals Private Limited Company
    • 9.11.1 Company Information
    • 9.11.2 Company Overview
    • 9.11.3 Company Product Offerings
    • 9.11.4 Company Financials, 2019
    • 9.11.5 Company Recent Developments
    • 9.11.6 Company SWOT Analysis
    • 9.11.7 Company Key Competitors in the Global CMO Market

10 Conclusion and Recommendations

  • 10.1 Will Product Reformulation Drive Growth to 2031?
  • 10.2 Demand for Biopharma Manufacturing Will Drive Growth 2021-2031
  • 10.3 Demand Will Be Highest Among Developed-Market Clients
  • 10.4 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2031?

11 List of Other 50 Pharmaceutical Contract Manufacturing Companies

12 Glossary

List of Tables

  • Table 2.1 Global Pharmaceutical Contract Manufacturing Market Summary Table
  • Table 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %)
  • Table 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %)
  • Table 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 6.1 Services Provided by Leading Pharmaceutical Contract Manufacturing Companies, 2019
  • Table 6.2 Global Market Share of Contract Manufacturing Companies Providing Bulk Drugs and APIs, 2019 (%)
  • Table 6.3 Global Market Share of Contract Manufacturing Companies Providing Solid Dosage Forms, 2019, (%)
  • Table 6.4 Global Market Share of Contract Manufacturing Companies Providing Nonsterile Liquid Dosage Forms, 2019 (%)
  • Table 6.5 Global Market Share of Contract Manufacturing Companies Providing Sterile Liquid Dosage Forms, 2019
  • Table 6.6 Global Market Share of Contract Manufacturing Companies Providing Semi-Solid Dosage Forms, 2019 (%)
  • Table 6.7 Services Provided by Leading Research Firms, 2019
  • Table 6.8 Global Market Share of Contract Research Companies, 2019
  • Table 6.9 Contracting Companies Offering Drug-Delivery Technologies and Systems, 2019
  • Table 7.1 Johnson & Johnson: Company Information
  • Table 7.2 Johnson & Johnson: Company Product and Service Offerings
  • Table 7.3 Johnson & Johnson: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.4 Johnson & Johnson: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.5 Johnson & Johnson: Company Recent Developments till Dec,2020
  • Table 7.6 Johnson & Johnson: SWOT Analysis
  • Table 7.7 F. Hoffmann-La Roche Ltd: Company Information
  • Table 7.8 F. Hoffmann-La Roche Ltd: Company Product and Service Offerings
  • Table 7.9 F. Hoffmann-La Roche Ltd: Manufacturing Locations
  • Table 7.10 F. Hoffmann-La Roche Ltd: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.11 F. Hoffmann-La Roche Ltd: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.12 F. Hoffmann-La Roche Ltd: Company Recent Developments till Dec,2020
  • Table 7.13 F. Hoffmann-La Roche Ltd: SWOT Analysis
  • Table 7.14 Pfizer Pharmaceutical: Company Information
  • Table 7.15 Pfizer Pharmaceutical: Company Product and Service Offerings
  • Table 7.16 Pfizer Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.17 Pfizer Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.18 Pfizer Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.19 Pfizer Pharmaceutical: SWOT Analysis
  • Table 7.20 Bayer Pharmaceutics: Company Information
  • Table 7.21 Bayer Pharmaceutics: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.22 Bayer Pharmaceutics: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.23 Bayer Pharmaceutics: Company Product and Service Offerings
  • Table 7.24 Bayer Pharmaceutics: Manufacturing Locations
  • Table 7.25 Bayer Pharmaceutics: Company Recent Developments till Dec,2020
  • Table 7.26 Bayer Pharmaceutics: SWOT Analysis
  • Table 7.27 Novartis Pharmaceutical: Company Information
  • Table 7.28 Novartis Pharmaceutical: Company Product and Service Offerings
  • Table 7.29 Novartis Pharmaceutical: Manufacturing Locations
  • Table 7.30 Novartis Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.31 Novartis Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.32 Novartis Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.33 Novartis Pharmaceutical: SWOT Analysis
  • Table 7.34 Merck & Co. Inc: Company Information
  • Table 7.35 Merck & Co. Inc: Company Product and Service Offerings
  • Table 7.36 Merck & Co. Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.37 Merck & Co. Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.38 Merck & Co. Inc: Company Recent Developments till Dec,2020
  • Table 7.39 Merck & Co. Inc: SWOT Analysis
  • Table 7.40 GlaxoSmithKline Pharmaceutical: Company Information
  • Table 7.41 GlaxoSmithKline Pharmaceutical: Company Product and Service Offerings
  • Table 7.42 GlaxoSmithKline Pharmaceutical: Manufacturing Locations
  • Table 7.43 GlaxoSmithKline Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.44 GlaxoSmithKline Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.45 GlaxoSmithKline Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.46 GlaxoSmithKline Pharmaceutical: Company Name: SWOT Analysis
  • Table 7.47 Sanofi Pharmaceutical: Company Information
  • Table 7.48 Sanofi Pharmaceutical: Company Product and Service Offerings
  • Table 7.49 Sanofi Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.50 Sanofi Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.51 Sanofi Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.52 Sanofi Pharmaceutical: SWOT Analysis
  • Table 7.53 AbbVie Inc.: Company Information
  • Table 7.54 AbbVie Inc: Company Product and Service Offerings
  • Table 7.55 AbbVie Inc: Manufacturing Locations
  • Table 7.56 AbbVie Inc Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.57 AbbVie Inc Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.58 AbbVie Inc: Company Recent Developments till Dec,2020
  • Table 7.59 AbbVie Inc: SWOT Analysis
  • Table 7.60 Abbott Laboratories: Company Information
  • Table 7.61 Abbott Laboratories: Company Product and Service Offerings
  • Table 7.62 Abbott Laboratories: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.63 Abbott Laboratories: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.64 Abbott Laboratories: Company Recent Developments till Dec,2020
  • Table 7.65 Abbott Laboratories: SWOT Analysis
  • Table 7.66 Thermo Fisher Scientific Inc: Company Information
  • Table 7.67 Thermo Fisher Scientific Inc: Company Product and Service Offerings
  • Table 7.68 Thermo Fisher Scientific Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.69 Thermo Fisher Scientific Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.70 Thermo Fisher Scientific Inc: Company Recent Developments till Dec,2020
  • Table 7.71 Thermo Fisher Scientific Inc: SWOT Analysis
  • Table 7.72 AstraZeneca Pharmaceutical: Company Information
  • Table 7.73 AstraZeneca Pharmaceutical: Company Product and Service Offerings
  • Table 7.74 AstraZeneca Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.75 AstraZeneca Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.76 AstraZeneca Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.77 AstraZeneca Pharmaceutical: SWOT Analysis
  • Table 7.78 Eli Lily and Company: Company Information
  • Table 7.79 Eli Lily and Company: Company Product and Service Offerings
  • Table 7.80 Eli Lily and Company: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.81 Eli Lily and Company: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.82 Eli Lily and Company: Company Recent Developments till Dec,2020
  • Table 7.83 Eli Lily and Company: SWOT Analysis
  • Table 7.84 Gilead Science Inc: Company Information
  • Table 7.85 Gilead Science Inc: Company Product and Service Offerings
  • Table 7.86 Gilead Science Inc: Manufacturing Locations
  • Table 7.87 Gilead Science Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.88 Gilead Science Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.89 Gilead Science Inc: Company Recent Developments till Dec,2020
  • Table 7.90 Gilead Science Inc: SWOT Analysis
  • Table 7.91 DuPont Chemical: Company Information
  • Table 7.92 DuPont Chemical: Company Product and Service Offerings
  • Table 7.93 DuPont Chemical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.94 DuPont Chemical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.95 DuPont Chemical: Company Recent Developments till Dec,2020
  • Table 7.96 DuPont Chemical: SWOT Analysis
  • Table 7.97 Novo Nordisk Pharmaceutical: Company Information
  • Table 7.98 Novo Nordisk Pharmaceutical: Company Product and Service Offerings
  • Table 7.99 Novo Nordisk Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.100 Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.101 Novo Nordisk Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.102 Novo Nordisk Pharmaceutical: SWOT Analysis
  • Table 7.103 Merck KGaA: Company Information
  • Table 7.104 Merck KGaA: Company Product and Service Offerings
  • Table 7.105 Merck KGaA: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.106 Merck KGaA: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.107 Merck KGaA: Company Recent Developments till Dec,2020
  • Table 7.108 Merck KGaA: SWOT Analysis
  • Table 7.109 Siemens Healthineers Healthcare: Company Information
  • Table 7.110 Siemens Healthineers Healthcare: Company Product and Service Offerings
  • Table 7.111 Siemens Healthineers Healthcare: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.112 Siemens Healthineers Healthcare: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.113 Siemens Healthineers Healthcare: Company Recent Developments till Dec,2020
  • Table 7.114 Siemens Healthineers Healthcare: SWOT Analysis
  • Table 7.115 Becton Dickinson Medical device: Company Information
  • Table 7.116 Becton Dickinson Medical device: Company Product and Service Offerings
  • Table 7.117 Becton Dickinson Medical device: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.118 Becton Dickinson Medical device: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.119 Becton Dickinson Medical device: Company Recent Developments till Dec,2020
  • Table 7.120 Becton Dickinson Medical device: SWOT Analysis
  • Table 7.121 Teva Pharmaceutical: Company Information
  • Table 7.122 Teva Pharmaceutical: Company Product and Service Offerings
  • Table 7.123 Teva Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.124 Teva Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.125 Teva Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.126 Teva Pharmaceutical: SWOT Analysis
  • Table 7.127 Evonik Industries: Company Information
  • Table 7.128 Evonik Industries: Company Product and Service Offerings
  • Table 7.129 Evonik Industries: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.130 Evonik Industries: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.131 Evonik Industries: Company Recent Developments till Dec,2020
  • Table 7.132 Evonik Industries: SWOT Analysis
  • Table 7.133 Stryker Corporation: Company Information
  • Table 7.134 Stryker Corporation: Company Product and Service Offerings
  • Table 7.135 Stryker Corporation: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.136 Stryker Corporation: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.137 Stryker Corporation: Company Recent Developments till Dec,2020
  • Table 7.138 Stryker Corporation: SWOT Analysis
  • Table 7.139 Baxter Biopharma Solutions: Company Information
  • Table 7.140 Baxter Biopharma Solutions: Company Product and Service Offerings
  • Table 7.141 Baxter Biopharma Solutions: Manufacturing Locations
  • Table 7.142 Baxter Biopharma Solutions: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.143 Baxter Biopharma Solutions: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.144 Baxter Biopharma Solutions: Company Recent Developments till Dec,2020
  • Table 7.145 Baxter Biopharma Solutions: SWOT Analysis
  • Table 7.146 Boston Scientific Manufacturing: Company Information
  • Table 7.147 Boston Scientific Manufacturing: Company Product and Service Offerings
  • Table 7.148 Boston Scientific Manufacturing: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.149 Boston Scientific Manufacturing: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.150 Boston Scientific Manufacturing: Company Recent Developments till Dec,2020
  • Table 7.151 Boston Scientific Manufacturing: SWOT Analysis
  • Table 7.152 Koninklijke DSM N.V.: Company Information
  • Table 7.153 Koninklijke DSM N.V.: Company Product and Service Offerings
  • Table 7.154 Koninklijke DSM N.V.: Manufacturing Locations
  • Table 7.155 Koninklijke DSM N.V: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.156 Koninklijke DSM N.V: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.157 Koninklijke DSM N.V.: Company Recent Developments till Dec,2020
  • Table 7.158 Koninklijke DSM N.V.: SWOT Analysis
  • Table 7.159 CSL Limited Biotechnology: Company Information
  • Table 7.160 CSL Limited Biotechnology: Company Product and Service Offerings
  • Table 7.161 CSL Limited Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.162 CSL Limited Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.163 CSL Limited Biotechnology: Company Recent Developments till Dec,2020
  • Table 7.164 CSL Limited Biotechnology: SWOT Analysis
  • Table 7.165 Lonza Group AG: Company Information
  • Table 7.166 Lonza Group AG: Company Product and Service Offerings
  • Table 7.167 Lonza Group AG: Manufacturing Locations
  • Table 7.168 Lonza Group AG: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.169 Lonza Group AG: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.170 Lonza Group AG: Company Recent Developments till Dec,2020
  • Table 7.171 Lonza Group AG: SWOT Analysis
  • Table 7.172 McKesson Corporation Medical: Company Information
  • Table 7.173 McKesson Corporation Medical: Company Product and Service Offerings
  • Table 7.174 McKesson Corporation Medical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.175 McKesson Corporation Medical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.176 Mckesson Corporation Medical: Company Recent Developments till Dec,2020
  • Table 7.177 Mckesson Corporation Medical: SWOT Analysis
  • Table 7.178 Edwards Lifesciences: Company Information
  • Table 7.179 Edwards Lifesciences: Company Recent Developments till Dec,2020
  • Table 7.180 Edwards Lifesciences: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.181 Edwards Lifesciences: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.182 Edwards Lifesciences: Company Recent Developments till Dec,2020
  • Table 7.183 Edwards Lifesciences: SWOT Analysis
  • Table 7.184 Nipro Corporation: Company Information
  • Table 7.185 Nipro Corporation: Company Product and Service Offerings
  • Table 7.186 Nipro Corporation: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.187 Nipro Corporation: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.188 Nipro Corporation: Company Recent Developments till Dec,2020
  • Table 7.189 Nipro Corporation: SWOT Analysis
  • Table 7.190 PPD Inc: Company Information
  • Table 7.191 PPD Inc: Company Product and Service Offerings
  • Table 7.192 PPD Inc: Manufacturing Locations
  • Table 7.193 PPD Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.194 PPD Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.195 PPD Inc: Company Recent Developments till Dec,2020
  • Table 7.196 PPD Inc: SWOT Analysis
  • Table 7.197 Grifols Pharmaceutical: Company Information
  • Table 7.198 Grifols Pharmaceutical: Company Product and Service Offerings
  • Table 7.199 Grifols Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.200 Grifols Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.201 Grifols Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.202 Grifols Pharmaceutical: SWOT Analysis
  • Table 7.203 Biomerieux Biotechnology: Company Information
  • Table 7.204 Biomerieux Biotechnology Company: Company Product and Service Offerings
  • Table 7.205 Biomerieux Biotechnology Company: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.206 Biomerieux Biotechnology Company: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.207 Biomerieux Biotechnology Company: Company Recent Developments till Dec,2020
  • Table 7.208 Biomerieux Biotechnology Company: SWOT Analysis
  • Table 7.209 Aurobindo Pharma Limited: Company Information
  • Table 7.210 Aurobindo Pharma Limited: Company Product and Service Offerings
  • Table 7.211 Aurobindo Pharma Limited: Manufacturing Locations
  • Table 7.212 Aurobindo Pharma Limited: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.213 Aurobindo Pharma Limited: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.214 Aurobindo Pharma Limited: Company Recent Developments till Dec,2020
  • Table 7.215 Aurobindo Pharma Limited: SWOT Analysis
  • Table 7.216 Dr. Reddy's Laboratories: Company Information
  • Table 7.217 Dr. Reddy's Laboratories: Company Product and Service Offerings
  • Table 7.218 Dr. Reddy's Laboratories: Manufacturing Locations
  • Table 7.219 Dr. Reddy's Laboratories: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.220 Dr. Reddy's Laboratories: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.221 Dr. Reddy's Laboratories: Company Recent Developments till Dec,2020
  • Table 7.222 Dr. Reddy's Laboratories: SWOT Analysis
  • Table 7.223 Wuxi AppTec: Company Information
  • Table 7.224 Wuxi AppTec: Company Product and Service Offerings
  • Table 7.225 Wuxi AppTec: Manufacturing Locations
  • Table 7.226 Wuxi AppTec: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.227 Wuxi AppTec: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.228 Wuxi AppTec: Company Recent Developments till Dec,2020
  • Table 7.229 Wuxi AppTec: SWOT Analysis
  • Table 7.230 Huapont Life Sciences Co Ltd: Company Information
  • Table 7.231 Huapont Life Sciences Co Ltd: Company Product and Service Offerings
  • Table 7.232 Huapont Life Sciences Co Ltd: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.233 Huapont Life Sciences Co Ltd: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.234 Huapont Life Sciences Co Ltd: SWOT Analysis
  • Table 7.235 Zhejiang Hisun Pharmaceutical: Company Information
  • Table 7.236 Zhejiang Hisun Pharmaceutical: Company Product and Service Offerings
  • Table 7.237 Zhejiang Hisun Pharmaceutical: Manufacturing Locations
  • Table 7.238 Zhejiang Hisun Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.239 Zhejiang Hisun Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.240 Zhejiang Hisun Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.241 Zhejiang Hisun Pharmaceutical: SWOT Analysis
  • Table 7.242 Alkermes Biotechnology: Company Information
  • Table 7.243 Alkermes Biotechnology: Manufacturing Locations
  • Table 7.244 Alkermes Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.245 Alkermes Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.246 Alkermes Biotechnology: Company Recent Developments till Dec,2020
  • Table 7.247 Alkermes Biotechnology: SWOT Analysis
  • Table 7.248 Emergent BioSolutions: Company Information
  • Table 7.249 Emergent BioSolutions: Company Product and Service Offerings
  • Table 7.250 Emergent BioSolutions: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.251 Emergent BioSolutions: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.252 Emergent BioSolutions: Company Recent Developments till Dec,2020
  • Table 7.253 Emergent BioSolutions: SWOT Analysis
  • Table 7.254 Divi's Laboratories: Company Information
  • Table 7.255 Divi's Laboratories: Company Product and Service Offerings
  • Table 7.256 Divi's Laboratories: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.257 Divi's Laboratories: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.258 Divi's Laboratories: SWOT Analysis
  • Table 7.259 Bavarian Nordic: Company Information
  • Table 7.260 Bavarian Nordic: Company Product and Service Offerings
  • Table 7.261 Bavarian Nordic: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.262 Bavarian Nordic: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.263 Bavarian Nordic: Company Recent Developments till Dec,2020
  • Table 7.264 Bavarian Nordic: SWOT Analysis
  • Table 7.265 Strides Pharma Science Limited: Company Information
  • Table 7.266 Strides Pharma Science Limited: Company Product and Service Offerings
  • Table 7.267 Strides Pharma Science Limited: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.268 Strides Pharma Science Limited: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.269 Strides Pharma Science Limited: Company Recent Developments till Dec,2020
  • Table 7.270 Strides Pharma Science Limited: SWOT Analysis
  • Table 7.271 Consort Medical PLC: Company Information
  • Table 7.272 Consort Medical PLC: Company Product and Service Offerings
  • Table 7.273 Consort Medical PLC: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.274 Consort Medical PLC: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.275 Consort Medical PLC: Company Recent Developments till Dec,2020
  • Table 7.276 Consort Medical PLC: SWOT Analysis
  • Table 7.277 Catalent Pharma Solutions Inc: Company Information
  • Table 7.278 Catalent Pharma Solutions Inc: Company Product and Service Offerings
  • Table 7.279 Catalent Pharma Solutions Inc: Manufacturing Locations
  • Table 7.280 Catalent Pharma Solutions Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.281 Catalent Pharma Solutions Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.282 Catalent Pharma Solutions Inc: Company Recent Developments till Dec,2020
  • Table 7.283 Catalent Pharma Solutions Inc: SWOT Analysis
  • Table 7.284 Moderna Biotechnology: Company Information
  • Table 7.285 Moderna Biotechnology: Company Product and Service Offerings
  • Table 7.286 Moderna Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.287 Moderna Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.288 Moderna Biotechnology: Company Recent Developments till Dec,2020
  • Table 7.289 Moderna Biotechnology: SWOT Analysis
  • Table 7.290 Avid Bioservices, Inc: Company Information
  • Table 7.291 Avid Bioservices, Inc: Company Product and Service Offerings
  • Table 7.292 Avid Bioservices, Inc: Manufacturing Locations
  • Table 7.293 Avid Bioservices, Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.294 Avid Bioservices, Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.295 Avid Bioservices, Inc: Company Recent Developments till Dec,2020
  • Table 7.296 Avid Bioservices, Inc: SWOT Analysis
  • Table 7.297 Novavax Inc: Company Information
  • Table 7.298 Novavax Inc: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.299 Novavax Inc: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.300 Novavax Inc: Company Recent Developments till Dec,2020
  • Table 7.301 Novavax Inc: SWOT Analysis
  • Table 7.302 Inovio Pharmaceutical: Company Information
  • Table 7.303 Inovio Pharmaceutical: Company Product and Service Offerings
  • Table 7.304 Inovio Pharmaceutical: Manufacturing Locations
  • Table 7.305 Inovio Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.306 Inovio Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.307 Inovio Pharmaceutical: Company Recent Developments till Dec,2020
  • Table 7.308 Inovio Pharmaceutical: SWOT Analysis
  • Table 7.309 VBI Vaccines Biotechnology: Company Information
  • Table 7.310 VBI Vaccines Biotechnology: Company Product and Service Offerings
  • Table 7.311 VBI Vaccines Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
  • Table 7.312 VBI Vaccines Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
  • Table 7.313 VBI Vaccines Biotechnology: Company Recent Developments till Dec,2020
  • Table 7.314 VBI Vaccines Biotechnology: SWOT Analysis

List of Figure

  • Figure 3.1 Prominent Factors Affecting Growth of Pharmaceutical Contract Manufacturing Market
  • Figure 3.2 Market Drivers for Growth of Pharmaceutical Contract Manufacturing Market
  • Figure 3.3 Opportunities in the Global Pharmaceutical Contract Manufacturing Market
  • Figure 3.4 Growth Restrains in the Global Pharmaceutical Contract Manufacturing Market
  • Figure 3.5 SWOT Analysis of Pharmaceutical Contract Manufacturing Market
  • Figure 3.6 Porter's Five Forces Analysis of Pharmaceutical Contract Manufacturing Market
  • Figure 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %)
  • Figure 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (V-Shaped Recovery)
  • Figure 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (W-Shaped Recovery)
  • Figure 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (U-Shaped Recovery)
  • Figure 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (L-Shaped Recovery)
  • Figure 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %)
  • Figure 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (V-Shaped Recovery)
  • Figure 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (W-Shaped Recovery)
  • Figure 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (U-Shaped Recovery)
  • Figure 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (L-Shaped Recovery)
  • Figure 7.1 Johnson & Johnson: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.2 Johnson & Johnson: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.3 : Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.4 F. Hoffmann-La Roche Ltd: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.5 F. Hoffmann-La Roche Ltd: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.6 F. Hoffmann-La Roche Ltd: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.7 Pfizer Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.8 Pfizer Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.9 Pfizer Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.10 Bayer Pharmaceutics: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.11 Bayer Pharmaceutics: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.12 Bayer Pharmaceutics: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.13 Novartis Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.14 Novartis Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.15 Novartis Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.16 Merck & Co. Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.17 Merck & Co. Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.18 Merck & Co. Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.19 GlaxoSmithKline Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.20 GlaxoSmithKline Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.21 GlaxoSmithKline Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.22 Sanofi Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.23 Sanofi Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.24 Sanofi Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.25 AbbVie Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.26 AbbVie Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn) 2019 (US$Mn)
  • Figure 7.27 AbbVie Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.28 Abbott Laboratories: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.29 Abbott Laboratories: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.30 Abbott Laboratories: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.31 Thermo Fisher Scientific Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.32 Thermo Fisher Scientific Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.33 Thermo Fisher Scientific Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.34 AstraZeneca Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.35 AstraZeneca Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.36 AstraZeneca Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.37 Eli Lily and Company: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.38 Eli Lily and Company: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.39 Eli Lily and Company: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.40 Gilead Science Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.41 DuPont Chemical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.42 Novo Nordisk Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.43 Novo Nordisk Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.44 Novo Nordisk Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.45 Merck KGaA: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.46 Merck KGaA: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.47 Merck KGaA: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.48 Siemens Healthineers Healthcare: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.49 Siemens Healthineers Healthcare: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.50 Siemens Healthineers Healthcare: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.51 Becton Dickinson Medical device: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.52 Becton Dickinson Medical device: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.53 Becton Dickinson Medical device: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.54 Teva Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.55 Evonik Industries: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.56 Evonik Industries: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.57 Evonik Industries: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.58 Stryker Corporation: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.59 Stryker Corporation: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.60 Stryker Corporation: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.61 Baxter Biopharma Solutions: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.62 Baxter Biopharma Solutions: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.63 : Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.64 Boston Scientific Manufacturing: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.65 Boston Scientific Manufacturing: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.66 Boston Scientific Manufacturing: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.67 Koninklijke DSM N.V: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.68 CSL Limited Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.69 CSL Limited Biotechnology: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.70 CSL Limited Biotechnology: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.71 Lonza Group AG: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.72 Lonza Group AG: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.73 Lonza Group AG: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.74 McKesson Corporation Medical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.75 McKesson Corporation Medical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.76 McKesson Corporation Medical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.77 Edwards Lifesciences: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.78 Edwards Lifesciences: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.79 Edwards Lifesciences: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.80 Nipro Corporation: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.81 PPD Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.82 Grifols Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.83 Biomerieux Biotechnology Company: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.84 Biomerieux Biotechnology Company: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.85 Biomerieux Biotechnology Company: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.86 Aurobindo Pharma Limited: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.87 Aurobindo Pharma Limited: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.88 Dr. Reddy's Laboratories: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.89 Dr. Reddy's Laboratories: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.90 Dr. Reddy's Laboratories: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.91 Wuxi AppTec: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.92 Huapont Life Sciences Co Ltd: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.93 Zhejiang Hisun Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.94 Alkermes Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.95 Emergent BioSolutions: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.96 Divi's Laboratories: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.97 Divi's Laboratories: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.98 Bavarian Nordic: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.99 Bavarian Nordic: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.100 Bavarian Nordic: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.101 Strides Pharma Science Limited: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.102 Strides Pharma Science Limited: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.103 Consort Medical PLC: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.104 Consort Medical PLC: Company Regional Revenue Market Share Analysis 2019 (US$Mn) 2019 (US$Mn)
  • Figure 7.105 Consort Medical PLC: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.106 Catalent Pharma Solutions Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.107 Catalent Pharma Solutions Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
  • Figure 7.108 Catalent Pharma Solutions Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
  • Figure 7.109 Moderna Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.110 Avid Bioservices, Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.111 Novavax Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.112 Inovio Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
  • Figure 7.113 VBI Vaccines Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)

Top 50 Companies Profiled in the Report:

  • AbbVie Inc Company
  • Aenova Group Company
  • Ajinomoto Bio-Pharma Services Company
  • Alcami Corporation Company
  • Alkermes Biotechnology company
  • Almac Group Company
  • Aurobindo Pharma Ltd.
  • Avid Bioservices Inc.
  • Baxter Biopharma Solutions Company
  • Bayer AG Company
  • Biocon Limited Company
  • Biomay AG Company
  • Biophore India Pharmaceuticals Private Limited Company
  • Bora Pharmaceuticals Company
  • C.H. Boehringer Sohn AG & Ko. KG Company
  • Cambrex Corporation Company
  • Cardinal Health, Inc. Company
  • Catalent Pharma Solutions Inc.
  • Cepia Sanofi Company (Parental of Sanofi)
  • Charles River Laboratories International, Inc. Company
  • Consort Medical plc
  • Corden Pharma International Company
  • Daito Pharmaceutical Co., Ltd. Company
  • Delpharm SAS Company
  • Divi's Laboratories Ltd
  • DPT Laboratories, Ltd. (Mylan N.V.) Company
  • Dr. Reddy's Laboratories Company
  • Evonik Degussa Company
  • F. Hoffmann-La Roche Ltd
  • Famar S.A. Company
  • Fareva Pharmaceuticals Company
  • Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
  • GlaxoSmithKline Pharmaceutical Company
  • Huapont Life Sciences Co Ltd Company
  • Koninklijke DSM N.V. (Royal DSM) Company
  • Lonza AG Company
  • Nipro Corporation
  • Pfizer Company
  • Recipharm AB Company
  • SAFC Biosciences (Merck KGaA Subsidiaries) Company
  • Samsung Biologics Company
  • Siegfried Holding Company
  • Strides Pharma Science Limited Company
  • Teva Pharmaceuticals Company
  • Therapure Biopharma, Inc. Company
  • Thermo Fisher Scientific Inc.
  • UPM Pharmaceuticals Company
  • Vetter Pharma Company
  • WuXi AppTec Company
  • Zhejiang Hisun Pharmaceutical Company

List of Companies Mentioned in the Report:

  • AbbVie
  • Actavis
  • ADC Biotechnology
  • Aegerion Pharmaceuticals
  • Aenova Group
  • Aesica Pharma
  • Agensys
  • Agila Specialties
  • Ajinomoto Althea Inc
  • Alexion Pharmaceuticals
  • Almac Group
  • Althea Technologies
  • AMRI (Albany Molecular Research Inc)
  • API Corporation (APIC)
  • Aspen Pharmacare
  • Astellas
  • AstraZeneca
  • Banner Life Sciences
  • Banner Pharmacaps
  • Baring Private Equity Asia
  • Bausch & Lomb
  • Bayer Healthcare
  • Ben Venue Laboratories
  • Bend Research
  • Biogen Idec
  • BioIndustry Association (BIA)
  • Biotest
  • Blackstone Group
  • Boehringer Ingelheim
  • Boehringer Ingelheim BioXcellence
  • Bristol-Myers Squibb Company
  • Bushu Pharmaceuticals
  • Cambrex
  • Cambridge Major Laboratories
  • Catalent Pharma Solutions
  • Cedarburg Hauser
  • Cell Therapy Catapult
  • Celldex Therapeutics
  • Celltrion
  • Cenexi
  • Chemisch-Pharmazeutisches Laboratorium Ravensburg
  • Chemtrix
  • China FDA (CFDA)
  • Cipla
  • Cook Pharmica
  • CordenPharma
  • CTC Bio
  • Daito Pharmaceutical
  • Delpharm
  • Dishman Pharmaceuticals
  • DPx Fine Chemicals
  • DPx Holdings B.V.
  • Dr. Reddy's Laboratories
  • DSP (DSM Sinochem Pharmaceuticals)
  • Eisai
  • Eli Lilly
  • Esteve Quimica
  • Euticals
  • Evonik Degussa
  • Famar
  • Fareva
  • FUJIFILM Diosynth Biotechnologies,
  • G-CON
  • Gallus Biopharmaceutical, LLC.
  • GEA Pharma-Systems
  • Genentech
  • GlaxoSmithKline (GSK)
  • Granules India
  • Haupt Pharma
  • Hexal
  • Hospira
  • Hospira One2One
  • ImmunoGen
  • Immunomedics
  • Indian Pharmaceutical Alliance
  • Innovent Biologics
  • IRIX Pharmaceuticals
  • Janssen
  • JK Pharmaceutical
  • Johnson & Johnson
  • Knowledge Transfer Network (KTN)
  • Lonza
  • Lupin
  • Marinopoulos Group
  • Matrix Laboratories
  • Medice
  • Medichem
  • Merck & Co.
  • Micron Technologies
  • Millennium
  • Mitsui & Co
  • Momenta Pharmaceuticals
  • Mylan
  • Neuland Laboratories
  • NICE Insight
  • NPS Pharmaceuticals
  • Nycomed
  • Orchid Chemicals & Pharmaceuticals
  • Oxford Biomedica
  • Patheon
  • Patheon Biologics
  • Pfizer
  • Pharmapak Technologies
  • Piramal Pharma Solutions
  • Progenics
  • Quintiles
  • Recepta Biopharma
  • Recipharm
  • Redwood Bioscience
  • Rentschler Biotechnologie
  • Roche
  • Royal DSM
  • SAFC
  • SafeBridge
  • Samsung Bioepis
  • Samsung BioLogics
  • Sandoz
  • Sanofi
  • Seattle Genetics
  • Shandong Xinhua
  • ShangPharma
  • Shire
  • Siegfried AG
  • Sigmar Italia
  • SMS Pharmaceuticals
  • Solvias AG
  • Speedel
  • Stada
  • Stem CentRx
  • Stevenage Bioscience Catalyst
  • Takeda
  • Temmler Group
  • Teva API
  • Thermo Fisher Scientific
  • UMN Pharma
  • UNIGEN
  • Valeant Pharmaceuticals
  • Valerion Therapeutics, LLC.
  • Vetter Pharma-Fertigung GmbH
  • Vivante GMP Solutions
  • West Pharmaceutical Services
  • WuXi PharmaTech
  • Zhangjiang Biotech & Pharmaceutical Base Company
  • Zhejiang Jiang Yuan Tang Biotechnology

List or Organizations Mentioned in the Report:

  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • Asociación Española de Fabricantes de Productos de Química Fina (AFAQUIM)
  • Associação Brasileira da Indústria Farmoquímica e de Insumos Farmacêuticos (ABIQUIFI)
  • Association of British Pharmaceutical Industry (ABPI)
  • Central Drugs Standard Control Organization (CDSCO)
  • Department of Health and Family Welfare
  • Development and Reform Commission (NDRC)
  • European Commission
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • Indian Drug Manufacturer's Association (IDMA)
  • International Society of Pharmaceutical Engineering (IPSE)
  • Korea Food and Drug Administration (KFDA)
  • Korea Pharmaceutical Manufacturer's Association (KPMA)
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medicines Manufacturing Industry Partnership (MMIP)
  • Ministry of Health (MOH)
  • Ministry of Health, Labor and Welfare (MHLW)
  • Ministry of Industry and Information Technology (MIIT)
  • Pharmaceutical and Medical Devices Agency (PMDA)
  • World Health Organization (WHO)